INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, cilt.11, sa.7, ss.1090-1095, 2018 (SCI-Expanded)
AIM: To evaluate the inhibitory effect of subconjunctival bevacizumab as single- and multiple-dose application, and compare their effects on corneal neovascularization in a rat model.